Oramed Pharmaceuticals
ORMP
ORMP
56 hedge funds and large institutions have $5.99M invested in Oramed Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
27% less capital invested
Capital invested by funds: $8.15M → $5.99M (-$2.16M)
Holders
56
Holding in Top 10
–
Calls
$158K
Puts
$75K
Top Buyers
| 1 | +$756K | |
| 2 | +$164K | |
| 3 | +$71.2K | |
| 4 |
LPL Financial
San Diego,
California
|
+$54.8K |
| 5 |
Squarepoint
New York
|
+$48.8K |
Top Sellers
| 1 | -$281K | |
| 2 | -$197K | |
| 3 | -$194K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$179K |
| 5 |
SRC
Samson Rock Capital
London,
United Kingdom
|
-$132K |